These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22428883)

  • 1. Pharmacodynamic bioequivalence testing.
    Li S
    J Clin Pharm Ther; 2012 Oct; 37(5):497-8. PubMed ID: 22428883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic comparison of two formulations of Acarbose 100-mg tablets.
    Lee S; Chung JY; Hong KS; Yang SH; Byun SY; Lim HS; Shin SG; Jang IJ; Yu KS
    J Clin Pharm Ther; 2012 Oct; 37(5):553-7. PubMed ID: 22428914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acarbose bioequivalence: exploration of new pharmacodynamic parameters.
    Zhang M; Yang J; Tao L; Li L; Ma P; Fawcett JP
    AAPS J; 2012 Jun; 14(2):345-51. PubMed ID: 22419151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose.
    Huang J; Liu WY; Yu JJ; Yang JB; Li M; Zou C; Guo CX; Yang XY; Yang S; Xie JL; Huang ZJ; Chen H; Pei Q; Yang GP
    Br J Clin Pharmacol; 2020 Nov; 86(11):2225-2233. PubMed ID: 32333407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.
    Lu D; Lee SL; Lionberger RA; Choi S; Adams W; Caramenico HN; Chowdhury BA; Conner DP; Katial R; Limb S; Peters JR; Yu L; Seymour S; Li BV
    AAPS J; 2015 May; 17(3):546-57. PubMed ID: 25758352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary report.
    O'Connor D; Adams WP; Chen ML; Daley-Yates P; Davis J; Derendorf H; Ducharme MP; Fuglsang A; Herrle M; Hochhaus G; Holmes SM; Lee SL; Li BV; Lyapustina S; Newman S; Oliver M; Patterson B; Peart J; Poochikian G; Roy P; Shah T; Singh GJ; Sharp SS
    J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):119-35. PubMed ID: 21453049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current regulatory approaches of bioequivalence testing.
    Karalis V; Macheras P
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):929-42. PubMed ID: 22681436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations.
    Joukhadar C; Schenk B; Kaehler ST; Kollenz CJ; Bauer P; Müller M; Eichler HG
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):631-6. PubMed ID: 14564429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PK/PD modelling of high-dose diltiazem--absorption-rate dependency of the hysteresis loop.
    Luckow V; Della Paschoa O
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):418-25. PubMed ID: 9352390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-Based Approach for Designing an Efficient Bioequivalence Study for Highly Variable Drugs.
    Song E; Lee W; Kim BH
    Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switchability of neoral and equoral according to Food and Drug Administration rules and regulations.
    Masri MA; Haberal M; Rizvi A; Stephan A; Bilgin N; Naqvi A; Barbari A; Kamel G; Zafar N; Emiroğlu R; Colak T; Manzoor K; Matha V; Kamarad V; Rost M; Rizk S; Hazime A; Perlik F
    Transplant Proc; 2005 Sep; 37(7):2988-93. PubMed ID: 16213282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on 'Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose' by Jie Huang et al.
    Zhang P; Lee J; Feng K; Babiskin A; Yoon M; Fang L; Zhao L
    Br J Clin Pharmacol; 2024 Sep; 90(9):2320-2322. PubMed ID: 38922996
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations.
    Sferrazza G; Siviero PD; Nicotera G; Turella P; Serafino A; Blandizzi C; Pierimarchi P
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):1007-1019. PubMed ID: 28656793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability and impact on design of bioequivalence studies.
    Van Peer A
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):146-53. PubMed ID: 20041877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologies.
    Maier GA; Lockwood GF; Oppermann JA; Wei G; Bauer P; Fedler-Kelly J; Grasela T
    Eur J Drug Metab Pharmacokinet; 1999; 24(3):249-54. PubMed ID: 10716064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine.
    Yacobi A; Zlotnick S; Colaizzi JL; Moros D; Masson E; Abolfathi Z; LeBel M; Mehta R; Golander Y; Levitt B
    Clin Pharmacol Ther; 1999 Apr; 65(4):389-94. PubMed ID: 10223775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.